Brief: Catalyst Pharmaceuticals Inc - District Court Delays Bench Trial To May 18, 2026 - SEC Filing
18/03/2026 21:36
March 18 (Reuters) - SEC Filing: CATALYST PHARMACEUTICALS INC - DISTRICT COURT DELAYS BENCH TRIAL TO MAY 18, 2026 - SEC FILING CATALYST PHARMACEUTICALS INC - BENCH TRIAL CONCERNS VALIDITY OF FIRDAPSE PATENTS EXPIRING IN 2032, 2034, 2037 - SEC FILING Source text: [ID:n0001193125-26-114306] Further company coverage: CPRX.O ((Reuters.Briefs@thomsonreuters.com;))